hers stock - Search News

Hims & Hers Stock Plummets. Wegovy Shortage Is Over.

Barron's on MSN · 21h

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Investopedia on MSN · 22h

Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply

Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Eli Lilly’s Wegovy and Novo Nordisk’s Ozempic has been resolved.

The Motley Fool on MSN · 22h

Why Hims & Hers Health Stock Is Plummeting Today

Shares of Hims & Hers Health (NYSE: HIMS) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as much as 26.1% earlier in the day. The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.

1don MSN

Why Hims & Hers Stock Dropped Today

Raising its price target on the shares to $21, reports The Fly, BofA nonetheless reiterated an "underperform" ( i.e., sell) ...

12h

Hims & Hers Health (HIMS) Projected to Post Quarterly Earnings on Monday

Hims & Hers Health (NYSE:HIMS – Get Free Report) is projected to announce its earnings results after the market closes on ...

SchaeffersResearch.com1d

Hims and Hers Stock Drops Weight as Earnings Loom

Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...

Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition

Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...

HIMS Stock: Is The Risk Worth The Reward?

We believe there is minimal cause for concern with HIMS stock, which makes it attractive but highly sensitive to adverse events as its current valuation is extremely ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results